These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Endocrine aspects of nephrolithiasis. Breslau NA, Pak CY. Spec Top Endocrinol Metab; 1982 Oct; 3():57-86. PubMed ID: 6302932 [No Abstract] [Full Text] [Related]
9. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. Parfitt AM. Miner Electrolyte Metab; 1982 Aug; 8(2):92-112. PubMed ID: 6762496 [No Abstract] [Full Text] [Related]
15. Long-term complications of dialysis: pathogenetic factors with special reference to bone. Delmez JA. Kidney Int Suppl; 1993 Jun; 41():S116-20. PubMed ID: 8320903 [No Abstract] [Full Text] [Related]
16. [Early symptoms of hyperparathyroidism in nephropathies]. Mampel E, Koall W, Hintner I. Z Gesamte Inn Med; 1977 Apr 01; 32(7):103-5. PubMed ID: 327710 [Abstract] [Full Text] [Related]
17. Renal disease and disorders of calcium metabolism. Kanis JA. Compr Ther; 1978 Aug 01; 4(8):44-50. PubMed ID: 688743 [No Abstract] [Full Text] [Related]
18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
19. [Evaluation of hyperparathyroidism and recurrent renal lithiasis]. Bernheim J, Pozet N, Zech P, Archimbaud JP, Dubernard JM, Traeger J, Perrin J. J Urol Nephrol (Paris); 1975 Nov 01; 81(10-11):824-30. PubMed ID: 1219134 [No Abstract] [Full Text] [Related]